Adalta Ltd has released a press release.
Toxicology study and manufacturing update
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from AdAlta
- Presentation of Eye Fobrosis Data at ARVO Meeting
- AdAlta expands partnership with Alfred Hospital
- AdAlta receives Orphan Designation for AD-114
- Positive Pre-clinical Data
- Commercialisation Agreement with Crossbeta Biosciences
Later from AdAlta
- AdAlta awarded SIEF grant
- Results of multi-dose toxicology study
- Conference Presentation
- Commercial agreement with XL-protein
- AdAlta granted key Australian Patent
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta